Trump Officials Halt COVID Vaccine Approvals for Healthy Individuals
The FDA announced a significant policy shift, ending routine annual COVID-19 vaccinations for healthy younger adults and children. Future COVID-19 vaccine approvals will require extensive studies, prioritizing high-risk individuals (adults 65+ and those with underlying health conditions). This new framework, published in the *New England Journal of Medicine*, marks a departure from the previous “one-size-fits-all” approach and raises concerns about vaccine accessibility and insurability. The decision follows criticism of the U.S.’s aggressive booster recommendations compared to other nations.
John Q. Hosedrinker